Cathie Wood’s ARK ETFs have made their latest round of daily trades on Tuesday, 01 July 2025, with significant activity ...

Catalio Capital Management announced the closing of its more than $400 million Fund IV. The fund will continue the firm’s ...

The EC received a total of 76 expressions of interest proposing to set up AI gigafactories in 16 member states across 60 ...

Microbiome science has deep roots, centuries of fermentation practices, and decades of bacterial taxonomy, but its modern incarnation is only just maturing.

Atai Life Sciences’ psychedelic drug has successfully reduced the symptoms of depression in a phase 2 study, triggering the next stage of the biotech’s planned merger with mental health company ...

T-knife Therapeutics, Inc., a biopharmaceutical company developing T cell receptor (TCR) engineered T cell therapies (TCR-T) to fight cancer, today announced the appointment of Christoph Broja, a ...

Proposals for drug exclusivities and feeble measures to combat drug shortages are unlikely to boost innovation, say some ...

In February 2025 Harbour BioMed announced that the IND application for HBM9378 (SKB378), a TSLP-targeting monoclonal antibody ...

Jeff Liter, CEO of Luminary, discusses his company’s approach to CAR-T therapies and why the developing Saudi market has ...

Lamark Biotech has raised Rs 6.5 crore in a pre-Series A round led by IAN Group, including IAN Alpha Fund, powered by ...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...